Hunan Jingfeng Pharmaceutical (000908) — Financial Flexibility Index
Hunan Jingfeng Pharmaceutical (000908) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of CN¥126.51 Million (operating CF CN¥125.78 Million minus capex CN¥729.48K) represents 0% of total liabilities (CN¥915.74 Million). Check Hunan Jingfeng Pharmaceutical total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Jingfeng Pharmaceutical Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for Hunan Jingfeng Pharmaceutical across 26 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hunan Jingfeng Pharmaceutical.
Annual Financial Flexibility Index for Hunan Jingfeng Pharmaceutical (1999–2024)
Year-by-year free cash flow to debt coverage for Hunan Jingfeng Pharmaceutical. Explore Hunan Jingfeng Pharmaceutical cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.00x | CN¥-4.17 Million | CN¥-5.55 Million | CN¥955.11 Million | ▼ -111.7% |
| 2023 | 0.04x | CN¥45.48 Million | CN¥35.06 Million | CN¥1.21 Billion | ▼ -65.7% |
| 2022 | 0.11x | CN¥136.78 Million | CN¥123.27 Million | CN¥1.25 Billion | ▼ -1.3% |
| 2021 | 0.11x | CN¥161.95 Million | CN¥123.83 Million | CN¥1.46 Billion | ▲ +229.2% |
| 2020 | -0.09x | CN¥-175.64 Million | CN¥-271.68 Million | CN¥2.05 Billion | ▼ -237.6% |
| 2019 | 0.06x | CN¥149.81 Million | CN¥36.17 Million | CN¥2.41 Billion | ▼ -71.8% |
| 2018 | 0.22x | CN¥522.05 Million | CN¥350.94 Million | CN¥2.37 Billion | ▲ +10.1% |
| 2017 | 0.20x | CN¥454.88 Million | CN¥151.65 Million | CN¥2.27 Billion | ▲ +90.7% |
| 2016 | 0.11x | CN¥265.13 Million | CN¥12.32 Million | CN¥2.52 Billion | ▼ -60.2% |
| 2015 | 0.26x | CN¥315.58 Million | CN¥92.37 Million | CN¥1.19 Billion | ▼ -20.7% |
| 2014 | 0.33x | CN¥306.53 Million | CN¥205.93 Million | CN¥919.76 Million | ▲ +6485.7% |
| 2013 | -0.01x | CN¥-1.73 Million | CN¥-3.44 Million | CN¥331.47 Million | ▼ -140.6% |
| 2012 | 0.01x | CN¥5.53 Million | CN¥351.50K | CN¥430.29 Million | ▲ +367.5% |
| 2011 | 0.00x | CN¥-2.02 Million | CN¥-6.87 Million | CN¥420.66 Million | ▲ +82.4% |
| 2010 | -0.03x | CN¥-11.28 Million | CN¥-15.21 Million | CN¥413.53 Million | ▼ -15178.7% |
| 2009 | 0.00x | CN¥-122.19K | CN¥-11.88 Million | CN¥684.14 Million | ▼ -100.2% |
| 2008 | 0.09x | CN¥57.92 Million | CN¥31.02 Million | CN¥650.60 Million | ▼ -19.6% |
| 2007 | 0.11x | CN¥52.84 Million | CN¥52.26 Million | CN¥477.43 Million | ▼ -8.1% |
| 2006 | 0.12x | CN¥58.52 Million | CN¥57.90 Million | CN¥486.08 Million | ▲ +205.7% |
| 2005 | -0.11x | CN¥-58.15 Million | CN¥-59.49 Million | CN¥510.48 Million | ▲ +58.5% |
| 2004 | -0.27x | CN¥-150.89 Million | CN¥-156.37 Million | CN¥550.11 Million | ▼ -510.5% |
| 2003 | 0.07x | CN¥37.66 Million | CN¥22.51 Million | CN¥563.64 Million | ▼ -80.4% |
| 2002 | 0.34x | CN¥117.41 Million | CN¥17.59 Million | CN¥343.98 Million | ▼ -41.9% |
| 2001 | 0.59x | CN¥72.00 Million | CN¥30.50 Million | CN¥122.47 Million | ▲ +464.5% |
| 2000 | 0.10x | CN¥20.55 Million | CN¥-25.05 Million | CN¥197.38 Million | ▼ -32.6% |
| 1999 | 0.15x | CN¥31.92 Million | CN¥13.64 Million | CN¥206.51 Million | — |